Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.

Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute ... if the President cannot force price cuts. Novo Nordisk shares have an ...

"Some prescription drugs and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%," said Trump. This would apply to commercial and Medicare ... cuts down the price to ...

The order also called to match the Medicare payment for certain prescription drugs to the price that hospitals pay for those drugs, up to 35% lower than what the government pays to acquire those ...

President Trump signed an executive order Monday meant to slash Americans’ pharmaceutical costs by up to 90% by tying the price paid by government programs like Medicare to the rates drug ...

(Reuters) -The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early ...